Form4.ai tracks every SEC insider trade in real time. See every AMPH insider filing with a free account — no card.

See every AMPH insider filing

Free account

Amphastar Pharmaceuticals, Inc. (AMPH) Insider Trading

Amphastar Pharmaceuticals, Inc. (AMPH) has 5 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 4 sales totalling $625K. Most recent filing: Sept. 23, 2026.

Bought vs sold

Open-market value, last 90 days

Sold: $625K (100%)
  • Sold $625K · 100%

What insiders filed

Form 4 filings by type, last 90 days

Sales: 4 (80%) Grants, exercises & other: 1 (20%)
  • Sales 4 · 80%
  • Grants, exercises & other 1 · 20%

At a glance

Insiders trading
3
Largest buy
—
Most recent filing
Sep 23, 2026

Latest AMPH Form 4 filings

Date Insider Trade Value Price since buy
Sep 23, 2026 SEC filing PETERS WILLIAM J CFO, EVP & TREASURER Sold $103,475 —
Sep 17, 2026 SEC filing Zhou Rong SENIOR EVP, PRODUCTION CENTER Cashless exercise $105,904 —
Sep 3, 2026 SEC filing Zhou Rong SENIOR EVP, PRODUCTION CENTER Sold $75,306 —

See every AMPH insider trade

Create a free account to see all 5 AMPH filings from the last 90 days. No card needed.

Create free account

Want AMPH insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days

Insiders are buying right now in other stocks too. See the latest insider trades across the market.

About this data

Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.